Aspire Biopharma Holdings annual current ratio
2021
2022
2023
2024
2025
Aspire Biopharma Holdings Current Ratio Growth & History (ASBP)
Aspire Biopharma Holdings's current ratio was 0.17 for fiscal 2025.
View full Aspire Biopharma Holdings company overviewAspire Biopharma Holdings annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.17 | 0.09 | +97.13% |
| 2024 | 2024-12-31 | 0.09 | −0.11 | −56.47% |
| 2023 | 2023-12-31 | 0.20 | −3.42 | −94.44% |
| 2022 | 2022-12-31 | 3.62 | 2.62 | +262.49% |
| 2021 | 2021-12-31 | 1.00 | — | — |
Aspire Biopharma Holdings quarterly current ratio
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 7.99 | 7.89 | +8420.63% |
| Q1 2026 | 2026-03-31 | 2.26 | 2.04 | +918.72% |
| Q4 2025 | 2025-12-31 | 0.17 | 0.09 | +97.13% |
| Q3 2025 | 2025-09-30 | 0.17 | 0.16 | +1743.75% |
| Q2 2025 | 2025-06-30 | 0.09 | 0.04 | +70.53% |
| Q1 2025 | 2025-03-31 | 0.22 | 0.20 | +789.95% |
| Q4 2024 | 2024-12-31 | 0.09 | −0.11 | −56.47% |
| Q3 2024 | 2024-09-30 | 0.01 | −0.79 | −98.83% |
| Q2 2024 | 2024-06-30 | 0.05 | −1.87 | −97.14% |
| Q1 2024 | 2024-03-31 | 0.02 | −2.52 | −99.02% |
| Q4 2023 | 2023-12-31 | 0.20 | −3.42 | −94.44% |
| Q3 2023 | 2023-09-30 | 0.80 | −5.27 | −86.82% |
| Q2 2023 | 2023-06-30 | 1.92 | −6.33 | −76.73% |
| Q1 2023 | 2023-03-31 | 2.54 | −21.86 | −89.58% |
| Q4 2022 | 2022-12-31 | 3.62 | 2.62 | +262.49% |
| Q3 2022 | 2022-09-30 | 6.08 | — | — |
| Q2 2022 | 2022-06-30 | 8.25 | — | — |
| Q1 2022 | 2022-03-31 | 24.40 | — | — |
| Q4 2021 | 2021-12-31 | 1.00 | — | — |
Aspire Biopharma Holdings current ratio trends
Between the periods ended 2021-12-31 and 2025-12-31, Aspire Biopharma Holdings's current ratio decreased from 1.00 to 0.17, a change of −0.83. The latest reported quarter, Q2 2026, shows 7.99.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Aspire Biopharma Holdings source filings ↗